- Home
- KROS vs EGY Comparison
KROS vs EGY Comparison
Compare KROS & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | EGY |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 504.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | EGY |
|---|---|---|
| Price | $16.57 | $4.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $23.00 | $7.30 |
| AVG Volume (30 Days) | 266.1K | ★ 1.3M |
| Earning Date | 03-03-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 5.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.57 | 0.27 |
| Revenue | $246,718,000.00 | ★ $389,951,000.00 |
| Revenue This Year | $6,924.79 | N/A |
| Revenue Next Year | N/A | $17.44 |
| P/E Ratio | ★ $10.53 | $18.26 |
| Revenue Growth | ★ 37798.31 | N/A |
| 52 Week Low | $9.12 | $3.00 |
| 52 Week High | $22.55 | $5.38 |
Technical Indicators
Market Signals| Indicator | KROS | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 54.22 |
| Support Level | $16.31 | $4.68 |
| Resistance Level | $17.17 | $5.07 |
| Average True Range (ATR) | 0.63 | 0.24 |
| MACD | -0.13 | -0.06 |
| Stochastic Oscillator | 18.26 | 24.10 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.